Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies

Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Lahey, Timothy; Cu-Uvin, Susan; Wu, Zhijin; Mayer, Kenneth; Wright, Peter F.; Kappes, John C.; Ochsenbauer, Christina; Wira, Charles R.

doi:10.1371/journal.pone.0011366

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies

Published Date:

Jun 29 2010

Publisher's site:

http://dx.doi.org/10.1371/journal.pone.0011366 New Site Icon

Source:

PLoS One. 5(6).

[PDF-325.87 KB]

Details:

Personal Authors:

Ghosh, Mimi ; Fahey, John V. ; Shen, Zheng ; Lahey, Timothy ; Cu-Uvin, Susan ; ... More ▼

Keywords:

[+]

Pubmed ID:

20614007

Pubmed Central ID:

PMC2894072

Description:

Background

We investigated the impact of antimicrobials in cervicovaginal lavage (CVL) from HIV(+) and HIV(−) women on target cell infection with HIV. Since female reproductive tract (FRT) secretions contain a spectrum of antimicrobials, we hypothesized that CVL from healthy HIV(+) and (−) women inhibit HIV infection.

Methodology/Principal Findings

CVL from 32 HIV(+) healthy women with high CD4 counts and 15 healthy HIV(−) women were collected by gently washing the cervicovaginal area with 10 ml of sterile normal saline. Following centrifugation, anti-HIV activity in CVL was determined by incubating CVL with HIV prior to addition to TZM-bl cells. Antimicrobials and anti-gp160 HIV IgG antibodies were measured by ELISA. When CXCR4 and CCR5 tropic HIV-1 were incubated with CVL from HIV(+) women prior to addition to TZM-bl cells, anti-HIV activity in CVL ranged from none to 100% inhibition depending on the viral strains used. CVL from HIV(−) controls showed comparable anti-HIV activity. Analysis of CH077.c (clone of an R5-tropic, mucosally-transmitted founder virus) viral inhibition by CVL was comparable to laboratory strains. Measurement of CVL for antimicrobials HBD2, trappin-2/elafin, SLPI and MIP3α indicated that each was present in CVL from HIV(+) and HIV(−) women. HBD2 and MIP3α correlated with anti-HIV activity as did anti-gp160 HIV IgG antibodies in CVL from HIV(+) women.

Conclusions/Significance

These findings indicate that CVL from healthy HIV(+) and HIV(−) women contain innate and adaptive defense mechanisms that inhibit HIV infection. Our data suggest that innate endogenous antimicrobials and HIV-specific IgG in the FRT can act in concert to contribute toward the anti-HIV activity of the CVL and may play a role in inhibition of HIV transmission to women.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases
CDC Public Access

Funding:

Supporting Files:

	pone.0011366.g004.jpg	image/jpeg
	pone.0011366.nxml	text/plain
	pone.0011366.t001.gif	image/gif
	pone.0011366.t001.jpg	image/jpeg
	pone.0011366.t002.gif	image/gif
	pone.0011366.t002.jpg	image/jpeg
	pone.0011366.t003.gif	image/gif
	pone.0011366.t003.jpg	image/jpeg
	pone.0011366.t004.gif	image/gif
	pone.0011366.t004.jpg	image/jpeg
	license.txt	text/plain
	pone.0011366.t005.gif	image/gif
	pone.0011366.t005.jpg	image/jpeg
	pone.0011366.g001.gif	image/gif
	pone.0011366.g001.jpg	image/jpeg
	pone.0011366.g002.gif	image/gif
	pone.0011366.g002.jpg	image/jpeg
	pone.0011366.g003.gif	image/gif
	pone.0011366.g003.jpg	image/jpeg
	pone.0011366.g004.gif	image/gif

No Related Documents.

You May Also Like:

Sexually transmitted diseases treatment guidelines 2002

Personal Author:

Workowski, Kimberly A.; Levine, William C.;

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

May 10, 2002

Series:

MMWR. Morbidity and mortality weekly report. Recommendations and reports ; v. 51, no. RR-6

Description:

NPIN 31074: "These guidelines for the treatment of patients who have sexually transmitted diseases (STDs) were developed by the Centers for Disease Control and Prevention (CDC) after consultation with a group of professionals knowledgeable in the fie...

Status:

superseded

File Type:

[PDF - 600.77 KB]
Sexually transmitted diseases treatment guidelines, 2006

Personal Author:

Workowski, Kimberly A.; Berman, Stuart M.;

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

August 4, 2006

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-11):1-94.

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports; v. 55, no. RR-11

Description:

"These guidelines for the treatment of persons who have sexually transmitted diseases (STDs) were developed by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta, Georgia, during April 19-21, 20...

Status:

superseded

File Type:

[PDF - 928.13 KB]
Sexually transmitted diseases treatment guidelines, 2015

Personal Author:

Workowski, Kimberly A.; Bolan, Gail;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.

Published:

June 5, 2015

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 64, no. RR-3

Description:

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30–Ma...

Status:

current

File Type:

[PDF - 1.39 MB]
Sexually transmitted diseases treatment guidelines, 2010

Personal Author:

Workowski, Kimberly A.; Berman, Stuart M.;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of STD Prevention.. Centers for Diseases Control and Prevention (U.S.).

Published:

December 17, 2010

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports; v. 59, no. RR-12

Description:

"These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18-30,...

File Type:

[PDF - 1.97 MB]
Sexually Transmitted Diseases Treatment Guidelines, 2015

Personal Author:

Workowski, Kimberly A.; Bolan, Gail A.;

Published:

Jun 05 2015

Source:

MMWR Recomm Rep. 64(RR-03):1-137.

Description:

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30-May ...

File Type:

[PDF - 1.35 MB]